Evidence map›Paper›PMID 27122598›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2016

Physiology, Biochemistry, and Applications of F420- and Fo-Dependent Redox Reactions.

Chris Greening, F Hafna Ahmed, A Elaaf Mohamed, Brendon M Lee, Gunjan Pandey, Andrew C Warden, Colin Scott, John G Oakeshott, Matthew C Taylor, Colin J Jackson

Open access · bronzeAbstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 192 citations in OpenAlex.

  1. Semiartificial COChemical reviews · 2026
    Review
  2. Article
  3. Review
  4. Molecules (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Diversity of Archaea.Progress in molecular and subcellular biology · 2026
    Review
  9. Recent Characterization of Key Proteins to Combat Tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  10. Article
  11. Article
  12. Pilot Scale Production of a FBiotechnology journal · 2025
    Article
  13. Review
  14. Review
  15. Article
  16. Cofactor FHeliyon · 2024
    Article
  17. Ethane-oxidising archaea couple CONature communications · 2024
    Article
  18. Article
  19. Review
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Chris GreeningThe Commonwealth Scientific and Industrial Research Organisation, Land & Water Flagship, Acton, Australian Capital Territory, Australia chris.greening@monash.edu colin.jackson@anu.edu.au.
F Hafna AhmedAustralian National University, Research School of Chemistry, Acton, Australian Capital Territory, Australia.
A Elaaf MohamedAustralian National University, Research School of Chemistry, Acton, Australian Capital Territory, Australia.
Brendon M LeeAustralian National University, Research School of Chemistry, Acton, Australian Capital Territory, Australia.
Gunjan PandeyThe Commonwealth Scientific and Industrial Research Organisation, Land & Water Flagship, Acton, Australian Capital Territory, Australia.
Andrew C WardenThe Commonwealth Scientific and Industrial Research Organisation, Land & Water Flagship, Acton, Australian Capital Territory, Australia.
Colin ScottThe Commonwealth Scientific and Industrial Research Organisation, Land & Water Flagship, Acton, Australian Capital Territory, Australia.
John G OakeshottThe Commonwealth Scientific and Industrial Research Organisation, Land & Water Flagship, Acton, Australian Capital Territory, Australia.
Matthew C TaylorThe Commonwealth Scientific and Industrial Research Organisation, Land & Water Flagship, Acton, Australian Capital Territory, Australia.
Colin J JacksonAustralian National University, Research School of Chemistry, Acton, Australian Capital Territory, Australia chris.greening@monash.edu colin.jackson@anu.edu.au.
CSIRO Land and Water · AUAustralian National University · AUCommonwealth Scientific and Industrial Research Organisation · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Deazaflavin cofactors enhance the metabolic flexibility of microorganisms by catalyzing a wide range of challenging enzymatic redox reactions. While structurally similar to riboflavin, 5-deazaflavins have distinctive and biologically useful electrochemical and photochemical properties as a result of the substitution of N-5 of the isoalloxazine ring for a carbon. 8-Hydroxy-5-deazaflavin (Fo) appears to be used for a single function: as a light-harvesting chromophore for DNA photolyases across the three domains of life. In contrast, its oligoglutamyl derivative F420 is a taxonomically restricted but functionally versatile cofactor that facilitates many low-potential two-electron redox reactions. It serves as an essential catabolic cofactor in methanogenic, sulfate-reducing, and likely methanotrophic archaea. It also transforms a wide range of exogenous substrates and endogenous metabolites in aerobic actinobacteria, for example mycobacteria and streptomycetes. In this review, we discuss the physiological roles of F420 in microorganisms and the biochemistry of the various oxidoreductases that mediate these roles. Particular focus is placed on the central roles of F420 in methanogenic archaea in processes such as substrate oxidation, C1 pathways, respiration, and oxygen detoxification. We also describe how two F420-dependent oxidoreductase superfamilies mediate many environmentally and medically important reactions in bacteria, including biosynthesis of tetracycline and pyrrolobenzodiazepine antibiotics by streptomycetes, activation of the prodrugs pretomanid and delamanid by Mycobacterium tuberculosis, and degradation of environmental contaminants such as picrate, aflatoxin, and malachite green. The biosynthesis pathways of Fo and F420 are also detailed. We conclude by considering opportunities to exploit deazaflavin-dependent processes in tuberculosis treatment, methane mitigation, bioremediation, and industrial biocatalysis.

Indexed as

AnimalsAnti-Bacterial AgentsArchaeaEuryarchaeotaFlavinsHumansMetabolic Networks and PathwaysMycobacteriumMycobacterium InfectionsOxidation-ReductionRiboflavin5-deazaflavinAnti-Bacterial Agentsfactor 420FlavinsRiboflavin

Identifiers

PMID27122598
PMCPMC4867364
OpenAlexW2343743473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.